Skip to main navigation Skip to search Skip to main content

Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: Tyrosine kinase inhibitors, donor lymphocyte infusions or both?

  • Ahmet Emre Eskazan
  • , Isil Erdogan
  • , Selin Berk
  • , Fevzi Firat Yalniz
  • , Tugrul Elverdi
  • , Ayse Salihoglu
  • , Teoman Soysal

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations
Original languageEnglish
Pages (from-to)2995-2996
Number of pages2
JournalLeukemia and Lymphoma
Volume56
Issue number10
DOIs
StatePublished - Oct 3 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: Tyrosine kinase inhibitors, donor lymphocyte infusions or both?'. Together they form a unique fingerprint.

Cite this